NAFDAC warns Nigerians about fake COVID-19 vaccines in circulation

The National Agency for Food and Drug Administration Control (NAFDAC) has issued a note of warning to Nigerians concerning fake Coronavirus vaccines in the country, as no vaccines have been approved by the agency.

This was said in a statement issued by the Director General of the agency, Mojisola Adeyeye. She said Nigerians should not use any vaccines that is not approved by NAFDAC.

The statement read, “The National Agency for Food and Drug Administration and Control (NAFDAC) has not received any application from Covid-19 vaccine manufacturers yet and therefore no vaccines have been approved by NAFDAC.

“COVID-19 vaccines are new, and the side effects or adverse events must be well monitored, therefore, if NAFDAC does not approve, the public should not use.”

The agency also called on Nigerians and other residents to beware of the vaccines as it can trigger Coronavirus-like illness and other serious disease that could kill.

The statement continued, “There are reports of fake vaccines in Nigeria. NAFDAC is pleading with the public to beware. No Covid-19 Vaccines have been approved by NAFDAC. Fake vaccines can cause Covid-like illnesses or other serious diseases that could kill.”

The agency however warned companies and corporations not to order for the vaccines, that if the manufacturers are genuine companies, they ought to know that they have to submit their application to the agency.

According to the statement, “Vaccines should not be ordered by any company or corporation. The companies that manufacture the vaccines if they are genuine companies know they have to submit their application to NAFDAC.”
 Mrs Adeyeye said there should be approval from NAFDAC before any government establishment or agency should order for the vaccines.

“NAFDAC is discussing with manufacturers of candidate COVID-19 vaccines concerning potential Emergency Use Authorization (EUA), registration or licensing of their product as the case may be.

“The Agency assures applicants that if Phase 3 clinical data are very convincing and robust with regards to safety and efficacy, and the vaccine has been submitted for WHO for Emergency Use Listing, NAFDAC will welcome the application for Emergency Use Authorisation in Nigeria,” read the statement.


Follow us on social media

Related Articles

Back to top button